Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy

Leukemia volume 17, pages 1100–1103 (2003)Cite this article

Abstract

Granulocytic sarcoma (GS) is an extramedullary tumor composed of immature myeloid cells. The objectives of this study were to describe the frequency, presenting characteristics, and survival in patients with nonleukemic GS by conducting a review of all untreated patients presenting to the MD Anderson Cancer Center between January 1990 and June 2002. In all, 21 patients with nonleukemic GS, 1520 patients with acute myeloid leukemia (AML), and 402 patients with high-risk myelodysplastic syndrome (MDS) were identified. GS occurred in 1.4% of patients with AML, and 1.1% of patients with AML or high-risk MDSs. The median patient age was 57 years (range, 7–81). Among 20 patients with available cytogenetics in tissue and/or bone marrow, six had chromosome 8 abnormalities. The median follow-up of surviving patients is 12 months (range, 7–75). In all, 20 patients were treated. Patients were treated with AML-type chemotherapy (n=16), chemotherapy and radiotherapy (n=3), or radiotherapy alone (n=1). A total of 13 patients (65%) achieved complete remission and one patient (5%) achieved partial remission. The median overall survival was 20 months (range, 1–75), median overall failure–free survival was 12 months (range, 1–75). The median survival of patients with chromosome 8 abnormalities was 12 months compared with 40 months of those without (P=0.17). Novel therapies for patients with GS are required.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Muss HB, Moloney WC . Chloroma and other myeloblastic tumors. Blood 1973; 42: 721–728.

    CAS  PubMed  Google Scholar 

  2. King A . A case of chloroma. Mon J Med 1853; 17: 97.

    Google Scholar 

  3. Rappaport H . Tumours of the hematopoietic system. In: Flo A (ed). Pathology: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC, 1966, pp 241–243.

    Google Scholar 

  4. Davey FR, Olson S, Kurec AS, Eastman-Abaya R, Gottlieb AJ, Mason DY . The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections. Am J Surg Pathol 1988; 12: 699–707.

    Article  CAS  Google Scholar 

  5. Menasce LP, Banerjee SS, Beckett E, Harris M . Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology 1999; 34: 391–398.

    Article  CAS  Google Scholar 

  6. Eshghabadi M, Shojania AM, Carr I . Isolated granulocytic sarcoma: report of a case and review of the literature. J Clin Oncol 1986; 4: 912–917.

    Article  CAS  Google Scholar 

  7. Meis JM, Butler JJ, Osborne BM, Manning JT . Granulocytic sarcoma in nonleukemic patients. Cancer 1986; 58: 2697–2709.

    Article  CAS  Google Scholar 

  8. Byrd JC, Edenfield WJ, Dow NS, Aylesworth C, Dawson N . Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia. Leukemia Lymphoma 1996; 21: 153–159.

    Article  CAS  Google Scholar 

  9. Mitelman F. ICSN. In: Karger S (ed). An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, 1995.

  10. Kaplan EL, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  11. National Cancer Institute. ‘Guidelines for Reporting of Adverse Drug Reactions’. Bethesda, MD: Division of Cancer Treatment, National Cancer Institute, 1988.

  12. Estey EH, Thall PF, Cortes JE, Giles FJ, O'Brien S, Pierce SA et al. Comparison of idarubicin+ara-C-, fludarabine+ara-C-, and topotecan+ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts. Blood 2001; 98: 3575–3583.

    Article  CAS  Google Scholar 

  13. Yamauchi K, Yasuda M . Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 2002; 94: 1739–1746.

    Article  Google Scholar 

  14. Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981; 48: 1426–1437.

    Article  CAS  Google Scholar 

  15. Imrie KR, Kovacs MJ, Selby D, Lipton J, Patterson BJ, Pantalony D et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med 1995; 123: 351–353.

    Article  CAS  Google Scholar 

  16. Huter O, Brezinka C, Nachbaur D, Schwaighofer H, Lang A, Niederwieser D . Successful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation. Bone Marrow Transplant 1996; 18: 663–664.

    CAS  PubMed  Google Scholar 

  17. Byrd JC, Weiss RB, Arthur DC, Lawrence D, Baer MR, Davey F et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol 1997; 15: 466–475.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    A-M Tsimberidou, H M Kantarjian, E Estey, J E Cortes, S Verstovsek, S Faderl, D A Thomas, G Garcia-Manero, A Ferrajoli, J T Manning, M J Keating, M Albitar, S O'Brien & F J Giles

  2. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

    A-M Tsimberidou, H M Kantarjian, E Estey, J E Cortes, S Verstovsek, S Faderl, D A Thomas, G Garcia-Manero, A Ferrajoli, J T Manning, M J Keating, M Albitar, S O'Brien & F J Giles

Authors
  1. A-M Tsimberidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H M Kantarjian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Estey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J E Cortes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Verstovsek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Faderl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D A Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G Garcia-Manero
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Ferrajoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J T Manning
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M J Keating
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M Albitar
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. S O'Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. F J Giles
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsimberidou, AM., Kantarjian, H., Estey, E. et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia 17, 1100–1103 (2003). https://doi.org/10.1038/sj.leu.2402958

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402958

Keywords

This article is cited by

Search

Advanced search

Quick links